ALLOX has announced the successful closing of its $10.5 million (€9.4m) seed financing round and the appointment of Morten Graugaard as Independent Chair of its Board of Directors. The round was led by Asabys, through its Sabadell Asabys II fund, with participation from CDTI with its SICC… Read More
Opentrons Labworks has announced a $40 million Series E financing led by healthcare investor Avego, with additional investment from BroadOak Capital Partners. Opentrons says it will use the capital to scale its robotics, software, and data infrastructure tools. While AI is transforming how science is… Read More
AstraZeneca and Tremont AI have announced a research collaboration to develop and evaluate AI solutions for accelerated safety screening in preclinical toxicologic pathology studies. Assessing the safety of a new drug is one of the most demanding steps before it can reach patients. Toxicologic pathologists… Read More
PREPAIR VAC is a Horizon Europe-funded research project aimed at strengthening pandemic preparedness through the application of artificial intelligence (AI) in vaccine design. NEC Corporation’s NEC OncoImmunity (NOI) will be working alongside several European partners comprising a research consortium. The four-year research grant beginning in… Read More
Partha Anbil and Satish Tadikonda explore the current state of AI agents in drug discovery, with a specific focus on clinical data harmonisation, the transition to autonomous laboratories, and the projected market growth that underscores this technological revolution. Introduction: The dawn of agentic AI Drug… Read More
A major new research study has identified potential new ways to treat the most common type of bowel cancer. The study, conducted by an international research team led by The Institute of Cancer Research, London and RCSI University of Medicine and Health Sciences, provides a roadmap for… Read More
R&D teams don’t need another chatbot. They need a team that can act on their behalf, guided by the scientists who know the science best. The future of R&D removes the toil of day-to-day work and connects the data scattered across your systems and teams. In this webinar, taking place… Read More
As drug discovery spans more modalities and more AI driven workflows, research teams face a growing challenge in keeping data connected and meaningful as it moves between people, systems and organisations. Here, Janice Darlington, Director of Customer Engagement at Collaborative Drug… Read More
R&D teams don’t need another chatbot. They need a team that can act on their behalf, guided by the scientists who know the science best. The future of R&D removes the toil of day-to-day work and connects the data scattered across your systems and teams. In this webinar, taking place… Read More
AstraZeneca and insitro have signed a worldwide exclusive research collaboration agreement to discover novel targets and therapeutics in metabolic dysfunction-associated steatohepatitis (MASH) and cardiomyopathies. Under the terms of the agreement, insitro will receive $40 million upfront and up to approximately $1.46 billion in potential discovery, development, and… Read More
R&D teams don’t need another chatbot. They need a team that can act on their behalf, guided by the scientists who know the science best. The future of R&D removes the toil of day-to-day work and connects the data scattered across your systems and teams. In this webinar, taking place… Read More
The results of a new study show AI/ML investment jumping after three flat years, with three quarters (76%) of respondents planning to increase spending on technology in the next two years, up from 60% in 2023, 62% in 2024, and 63% in 2025. However, the leading barrier… Read More
R&D teams don’t need another chatbot. They need a team that can act on their behalf, guided by the scientists who know the science best. The future of R&D removes the toil of day-to-day work and connects the data scattered across your systems and teams. In this webinar, taking place… Read More
R&D teams don’t need another chatbot. They need a team that can act on their behalf, guided by the scientists who know the science best. The future of R&D removes the toil of day-to-day work and connects the data scattered across your systems and teams. In this webinar, hosted by… Read More
R&D teams don’t need another chatbot. They need a team that can act on their behalf, guided by the scientists who know the science best. The future of R&D removes the toil of day-to-day work and connects the data scattered across your systems and teams. In this webinar, hosted by… Read More
R&D teams don’t need another chatbot. They need a team that can act on their behalf, guided by the scientists who know the science best. The future of R&D removes the toil of day-to-day work and connects the data scattered across your systems and teams. In this webinar, taking place… Read More
